Fendrix ® compared to Engerix® in HIV-infected patients nonresponding to initial- and re-vaccination schedule
CONCLUSION: These results together, suggest that continuing HBV vaccination in non-responders to a first course of single-dose vaccine and a double-dose revaccination scheme is worth the effort. No superiority of one of the investigated hepatitis B vaccines was shown in this cohort but an appropriate number of patients needed to achieve reliable answers was not achieved.PMID:33380535
Source: The Netherlands Journal of Medicine - Category: General Medicine Authors: T E M S de Vries-Sluijs E R Andrinopoulou R A de Man M E van der Ende Source Type: research
More News: General Medicine | Hepatitis | Hepatitis B | Hepatitis Vaccine | Netherlands Health | Study | Vaccines